semaglutide patent protection The upcoming expiry of the in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the development will open Ozempic's patent problem: how Novo

Let us help you improve your health and quality of life

No, like this is a big giant debilitating disease that needs to be taken seriously and we don't need to be minimizing people suffering from it and making them feel like they shouldn't take medication because of it

GLP-1 receptor agonists and SGLT2 inhibitors are two types of medications often used to help people with diabetes manage their blood sugar, M

Does the COA match the exact lot in hand

This piece looks at what science tells us about how semaglutide might affect anxiety

A syringe showing 40 units with an air bubble might actually contain only 35 units of solution